(Q44507077)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Jakub Krijt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Jaromir Hradec

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Tomáš Štulc

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Barbora Grauová

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Richard Češka

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Viktor Kozich

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Dan Wichterle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Tomas Haas

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Jan Malik

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

Homocysteine and atherosclerosis

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Cysteine is a cardiovascular risk factor in hyperlipidemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Hyperhomocysteinemia and oxidative stress: time for a reality check?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

The effect of cyst(e)ine on the auto-oxidation of homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Serum homocysteine increases after therapy with fenofibrate or bezafibrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Lipid-lowering drugs and homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Implication of fibrate therapy for homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Effects of fenofibrate and gemfibrozil on plasma homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Fenofibrate raises plasma homocysteine levels in the fasted and fed states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Plasma kinetics and elimination of folic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Fenofibrate induces a selective increase of protein-bound homocysteine in rodents: a PPARalpha-mediated effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Implication of fibrate therapy for homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Determinants of hyperhomocysteinemia: a matter of nature and nurture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Homocysteine and cardiovascular disease: current evidence and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900122-4

10.1016/S0002-8703(03)00122-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851616%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference